70653-54-2

Basic information

• Product Name: benzhydryl 7-[[2-(4-hydroxyphenyl)-3-(4-methoxybenzyloxy)-3-oxopropionyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
• Synonyms: benzhydryl 7-[[2-(4-hydroxyphenyl)-3-(4-methoxybenzyloxy)-3-oxopropionyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;7-[[2-(4-Hydroxyphenyl)-3-[(4-methoxyphenyl)methoxy]-1,3-dioxopropyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester
• CAS NO: 70653-54-2
• Molecular Formula: C41H38N6O10S
• Molecular Weight: 806.83962
• EINECS: 274-723-7
• Mol File: 70653-54-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.42±0.1 g/cm3 (20 ºC 760 Torr)
• Refractive Index: 1.673
• CAS DataBase Reference: benzhydryl 7-[[2-(4-hydroxyphenyl)-3-(4-methoxybenzyloxy)-3-oxopropionyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzhydryl 7-[[2-(4-hydroxyphenyl)-3-(4-methoxybenzyloxy)-3-oxopropionyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(70653-54-2)
• EPA Substance Registry System: benzhydryl 7-[[2-(4-hydroxyphenyl)-3-(4-methoxybenzyloxy)-3-oxopropionyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(70653-54-2)

Safety Data

• Hazardous Substances Data: 70653-54-2(Hazardous Substances Data)

Usage

General Description

The chemical compound "benzhydryl 7-[[2-(4-hydroxyphenyl)-3-(4-methoxybenzyloxy)-3-oxopropionyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" is a complex organic molecule with a long and detailed structural formula. It contains functional groups such as hydroxyl, methoxy, carboxylate, and tetrazolyl, as well as a bicyclic structure. This chemical likely exhibits a range of biological activities due to the presence of multiple aromatic rings, amine and thioether groups, and a highly functionalized carboxylate. The compound's extensive structure suggests that it may have potential applications in drug discovery or medicinal chemistry, although further research would be needed to fully understand and utilize its properties.

InChI:InChI=1/C41H38N6O10S/c1-46-40(43-44-45-46)58-24-29-23-56-39-41(54-3,38(52)47(39)33(29)37(51)57-34(27-10-6-4-7-11-27)28-12-8-5-9-13-28)42-35(49)32(26-16-18-30(48)19-17-26)36(50)55-22-25-14-20-31(53-2)21-15-25/h4-21,32,34,39,48H,22-24H2,1-3H3,(H,42,49)

Upstream product

• 66510-99-4 (6R,7R)-benzhydryl-7-amino-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate 

Relevant articles and documents

Latamoxef intermediate solvate, preparation method and representation thereof

The invention provides a latamoxef sodium intermediate solvate, a preparation method and representation thereof. According to the invention, the latamoxef sodium intermediate ethyl acetate solvate product is high in purity, good in stability and easy to store; the preparation process is simple, solvate is separated out by adopting a recrystallization method, the yield is high, and the quality is stable; and the used crystallization reagent has low toxicity, is safer and more environment-friendly, and is suitable for large-scale production of latamoxef sodium.